Construction Walls Going Up for Levels E and 1
Construction barrier walls for Levels E and 1 of the Medical Sciences Building (MSB) will start to go up the week of Aug. 12. The walls will allow construction access to the MSB Rehabilitation project Phase IV area while also maintaining access to other areas of the MSB.
Starting at 8 p.m. Monday, Aug. 12, walls will go up along the MSBs southernmost east/west corridor (intersecting with the main corridor, which runs north/south) from Room 1351 to a point across from Suite 1358. The wall will divide the existing corridor in half to allow access to the labs and offices that were part of Phase II (northeast quadrant) and are now occupied. All work in this area will be done by 6 a.m. Wednesday, Aug. 14.
Starting at 8 p.m. Tuesday, Aug. 13, the north/south corridor on Level 1 will have barrier walls installed in it from Room 1351 south to the double doors entrance from UC Medical Center. Access will still be available for this corridor between the medical center and the MSB, but with reduced width. All work in this area will be done by 6 a.m. Thursday, Aug. 15.
Starting at 8 p.m. Wednesday, Aug. 14, walls will go up along the MSBs Level E north/south corridor from Room E362 to Room E601A (about 60 feet from the double doors leading to Eden Garage and UC Medical Center). The wall will divide the existing corridor in half to allow access to the offices and spaces that were part of Phase III (southwest quadrant) and Phase II (northeast quadrant) and are now occupied. All work in this area will be done by 6 a.m. Tuesday, Aug. 20.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.